The department is  engaged in the development of new molecular cytogenetic techniques (array-CGH among others) and investigation of their clinical  usefulness. The department was the first in Scandinavia to offer prenatal array for foetuses with malformation as a first tier analyses. The detection rate is currently 10%. Follow-up results on usual screening parameters as well as rates of TOP, rate of miscarriage, birth and diagnoses will follow.

Contacts:

Ida Vogel or Else Marie Vestergard